Cognitive impairment and elevated peripheral cytokines in breast cancer patients receiving chemotherapy.

Mohd Ashif Khan Dinesh Bhurani Ubedul Hoda Nouroz Sehar Nidhi Bharal Agarwal

Published in: Arquivos de neuro-psiquiatria (2022)

Anthracycline-based regimen caused comparatively higher peripheral inflammation, which could be the reason for more decline in cognition in anthracycline-receiving patients than non-anthracycline group.

Keyphrases

cognitive impairment
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
oxidative stress
chemotherapy induced
prognostic factors
peritoneal dialysis
radiation therapy
patient reported outcomes
multiple sclerosis
mild cognitive impairment
locally advanced